Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies.

Osman Omer RadhwiHamza JanAbdullah WaheebSawsan S AlamriHatem M AlahwalIuliana DenetiuAshgan AlmanzlaweyAdel F Al-MarzoukiAbdullah T AlmohammadiSalem M BahashwanAhmed Saleh BarefahMohamad H QariAdel M AbuzenadahAnwar M Hashem

Published in: Vaccines (2022)

Our results provide supportive data when advising patients with hemoglobinopathy to receive COVID-19 vaccines and ensure booster doses are available for better immunity. Whenever available, measurement of nAb is recommended.

Keyphrases

coronavirus disease
sars cov
electronic health record
big data
advanced non small cell lung cancer
machine learning
binding protein
artificial intelligence